Millipore Sigma Vibrant Logo

Press Releases
Back to Previous Page

In the News

January 10, 2020

MilliporeSigma and CSIR-IMTECH Open High-tech Skill Development Center

  • Joint academia-industry-led lab is equipped with genome-editing, single-molecule biomarker detection and other technologies

Chandigarh, India, January 10, 2020 — MilliporeSigma, a leading science and technology company, today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies from MilliporeSigma experts.

“With the rapidly growing biopharmaceutical industry in India and demand for therapies, researchers who collaborate with us will benefit from our expertise to enhance their scientific competency and develop advanced technologies to accelerate development and production of new therapies,” said Sunil Punjabi, country speaker and head of Research Solutions, Life Science, India. “They will gain hands-on experience and enhance their skills in areas such as cancer research and novel drug development, conducting real-time analysis on their samples as part of workshops here.”

The center was developed by MilliporeSigma in collaboration with CSIR-IMTECH, an institute of the Council of Scientific and Industrial Research, under the aegis of Ministry of Science and Technology. It focuses on research, development and training in new drug discovery, affordable healthcare, fast and accurate diagnostics as well as agriculture biotechnology. Located in Chandigarh, the center augments the Indian government’s initiative for life science skill building in the country.

Dr. Shekhar C. Mande, director general CSIR & Secretary DSIR, said this collaboration would be a new benchmark for up scaling employability skills for graduates and post graduates who are interested in life science careers.

“India is a country today with 65 percent of its youth in the working age group (15-59 years) and more than 54 percent of its total population below 25 years of age,” Dr. Mande said. “If ever there is a way to reap this demographic advantage, it has to be through skill development of the youth and I am happy that IMTECH has a role to play.”